Anti-Inflammatory Mechanisms in Pain Management

Summary

Pain associated with tissue injury or chronic disease frequently involves an inflammatory component in which immune cells, inflammatory mediators and neural pathways interact to generate and sustain nociceptive signals. At the peripheral level, damage triggers the release of proinflammatory cytokines, chemokines and eicosanoids, notably prostaglandins synthesised by cyclooxygenase-2, which sensitise nociceptors and amplify pain transmission. Concurrently, local infiltration of neutrophils and macrophages perpetuates this activity through additional mediator release. In the central nervous system, microglia and astrocytes assume key roles by releasing cytokines and neuromodulators that heighten spinal and supraspinal sensitisation. Counter-regulatory processes include activation of transcription factors such as nuclear factor erythroid 2-related factor 2, which upregulates antioxidant defences, and the production of specialised pro-resolving mediators that promote termination of inflammation and tissue repair. Analgesia may also be achieved through modulation of inhibitory neurotransmitter systems, including endogenous opioids and GABAergic pathways. Modern strategies in pain management thus seek to shift the balance from proinflammatory to pro-resolving pathways, to inhibit key enzymes such as cyclooxygenase-2, and to engage central inhibitory circuits without incurring the adverse effects associated with long-term steroidal or opioid therapies. Emerging approaches harness natural products, novel small molecules and biologics to target multiple points in these intersecting pathways, offering the prospect of effective analgesia with minimised systemic toxicity.

Research from Nature Portfolio

Recent studies have illuminated the dual peripheral and central actions of dehydrocorydaline, an alkaloid that demonstrates potent antinociceptive effects in models of inflammatory pain. Administration of this compound in rodents reduced carrageenan-induced paw oedema and attenuated formalin-evoked nociceptive behaviours without impairing locomotor activity. Mechanistic investigations revealed involvement of central opioid receptors in mediating spinal analgesia and downregulation of proinflammatory cytokines, including tumour necrosis factor-α, interleukin-1β and interleukin-6, as well as reduced expression of caspase-6 in the spinal cord. These findings underscore the therapeutic potential of multi-target small molecules that can modulate both inflammatory cascades and central pain circuits.

Anti-Inflammatory Mechanisms in Pain Management publication trend

The graph below shows the total number of articles in anti-inflammatory mechanisms in pain management across all publications each year (not limited to Nature Index journals).

Technical terms

Antinociceptive: Reduction in the perception or transmission of painful stimuli.

Cytokine: Small signalling protein released by cells to modulate immune and inflammatory responses.

Cyclooxygenase-2 (COX-2): Enzyme that catalyses the formation of proinflammatory prostaglandins from arachidonic acid.

NF-κB: Transcription factor that regulates genes involved in inflammation and immune responses.

nuclear factor erythroid 2-related factor 2 (Nrf2): Transcription factor that induces expression of antioxidant and cytoprotective genes.

Opioid receptor: G-protein-coupled receptor mediating analgesia through endogenous or exogenous ligands.

Specialised pro-resolving mediators (SPMs): Lipid-derived compounds that actively resolve inflammation and promote tissue repair.

References

  1. Antinociceptive and antiinflammatory activities of crude leave extract and solvent fractions of Commelina latifolia Hochst. ex C.B.Clarke (Commelinaceae) leaves in murine model. Frontiers in Pharmacology (2023).
  2. Cleomin Exerts Acute Antinociceptive Effects in Mice via GABAB and Muscarinic Receptors. Pharmaceuticals (2023).
  3. Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines. Scientific Reports (2016).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.